Search Results - "Padrnos, Leslie J"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
  2. 2

    May‐Thurner syndrome and thrombosis: A systematic review of antithrombotic use after endovascular stent placement by J. Padrnos, Leslie, Garcia, David

    “…May‐Thurner Syndrome (MTS) is caused by compression of the left common iliac vein between the right common iliac artery and the pelvis. It likely predisposes…”
    Get full text
    Journal Article
  3. 3

    Immunotherapy in pancreatic cancer treatment: a new frontier by Thind, Komal, Padrnos, Leslie J., Ramanathan, Ramesh K., Borad, Mitesh J.

    Published in Therapeutic Advances in Gastroenterology (01-01-2017)
    “…Pancreatic cancer is a highly aggressive and lethal cancer characterized by high invasiveness, local and extensive dissemination at time of diagnosis and…”
    Get full text
    Book Review Journal Article
  4. 4

    Risk of venous thromboembolism after COVID‐19 vaccination by Houghton, Damon E., Wysokinski, Waldemar, Casanegra, Ana I., Padrnos, Leslie J., Shah, Surbhi, Wysokinska, Ewa, Pruthi, Rajiv, Ashrani, Aneel, Sridharan, Meera, Baumann‐Kreuziger, Lisa, McBane, Robert, Padmanabhan, Anand

    Published in Journal of thrombosis and haemostasis (01-07-2022)
    “…Background COVID‐19 vaccinations in the United States are effective in preventing illness and hospitalization yet concern over post‐vaccination venous…”
    Get full text
    Journal Article
  5. 5

    COVID-19 infection and risk stratification for pulmonary embolism: Identifying optimal D-dimer thresholds by Houghton, Damon E., Casanegra, Ana I., Wysokinski, Waldemar E., Padrnos, Leslie J., Wysokinska, Ewa, Pruthi, Rajiv, Heaton, Heather, Sridharan, Meera, McBane, Robert D., Shah, Surbhi

    Published in Thrombosis research (01-03-2024)
    “…[Display omitted] •The inflammatory effects of COVID-19 infection can increase d-dimer levels.•The validity of a d-dimer to assist in the risk stratification…”
    Get full text
    Journal Article
  6. 6

    Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19 by Pasha, Ahmed K., McBane, Robert D., Chaudhary, Rahul, Padrnos, Leslie J., Wysokinska, Ewa, Pruthi, Rajiv, Ashrani, Aneel, Daniels, Paul, Sridharan, Meera, Wysokinski, Waldemar E., Houghton, Damon E.

    Published in Thrombosis research (01-11-2021)
    “…The reported incidence of venous thromboembolism (VTE) in COVID-19 patients varies widely depending on patient populations sampled and has been predominately…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Venous thromboembolism after COVID‐19 vaccination in patients with thrombophilia by Houghton, Damon E., Wysokinski, Waldemar E., Padrnos, Leslie J., Shah, Surbhi, Wysokinska, Ewa, Pruthi, Rajiv, Ghorbanzadeh, Atefeh, Ashrani, Aneel, Sridharan, Meera, McBane, Robert D., Padmanabhan, Anand, Casanegra, Ana I.

    Published in American journal of hematology (01-04-2023)
    “…Patients with thrombophilia remain concerned about venous thromboembolism (VTE) risk with COVID‐19 vaccinations. The aim of this study was to examine VTE…”
    Get full text
    Journal Article
  9. 9

    Genomic profiling proves metastasis of cutaneous melanoma to vitreal fluid by Padrnos, Leslie J., Houghton, Odette M., Iacob, Codrin E., Kurli, Madhavi, Ocal, Idris T., Bryce, Alan H.

    Published in Melanoma research (01-12-2020)
    “…Cutaneous melanoma metastases can contribute to visual disturbances through a variety of factors, including metastasis to the vitreal fluid. The optimum…”
    Get full text
    Journal Article
  10. 10

    Comparative Effectiveness of Anticoagulants in Patients With Cancer-Associated Thrombosis by Riaz, Irbaz Bin, Fuentes, Harry, Deng, Yihong, Naqvi, Syed Arsalan Ahmed, Yao, Xiaoxi, Sangaralingham, Lindsey R, Houghton, Damon E, Padrnos, Leslie J, Shamoun, Fadi E, Wysokinski, Waldemar E, McBane, 2nd, Robert D

    Published in JAMA network open (03-07-2023)
    “…Patterns of clinical utilization and comparative effectiveness of anticoagulants for cancer-associated thrombosis (CAT) remain largely unexplored. To assess…”
    Get full text
    Journal Article
  11. 11

    Racial/ethnic differences in patients with anemia and folate deficiency by Gonzalez‐Velez, Miguel, Mead‐Harvey, Carolyn, Kosiorek, Heidi E., Kusne, Yael N., Rivera, Candido, Bojanini, Leyla, Northfelt, Donald W., Padrnos, Leslie J.

    “…Objective To determine the presence of racial/ethnic differences in patients with anemia and serum folate deficiency. Methods We performed a retrospective…”
    Get full text
    Journal Article
  12. 12

    Understanding and Information in Cancer Patients: The Impact of a Cancer Symposia on Patient Knowledge by Padrnos, Leslie J, Wu, Qing, Scherber, Robyn M, Northfelt, Donald W., Mikhael, Joseph R., Bennett, Robert M., Dueck, Amylou Constance, Mesa, Ruben

    Published in Blood (06-12-2014)
    “…Background: Patients diagnosed with cancer experience a significant influx of health care information while continuing to demonstrate understanding deficit…”
    Get full text
    Journal Article
  13. 13

    Living With Cancer: Assessing The Educational, Symptomatic, and Quality Of Life Impact Of a Comprehensive Patient Symposia On Cancer Patients by Padrnos, Leslie J, Dueck, Amylou Constance, Bennett, Robert M., Emanuel, Robyn M., Mesa, Ruben A., Northfelt, Donald, Mikhael, Joseph R., Glassley, Pamela, Stigge, Rachel, Aguirre, Annette

    Published in Blood (15-11-2013)
    “…Patients with cancer may face a significant knowledge deficit as they battle their illness. We developed a first of its kind comprehensive patient symposia…”
    Get full text
    Journal Article
  14. 14

    Introducing routine HIV screening for patients on an internal medicine residency inpatient service: a quality improvement project by Padrnos, Leslie, Barr, Patrick, Klassen, Christine, Fields, Heather, Azadeh, Natalya, Mendoza, Neil, Saadiq, Rayya, Pauwels, Emanuel, King, Chris, Chung, Andy, Sakata, Kenneth, Blair, Janis

    Published in BMJ quality improvement reports (2016)
    “…The US Centers for Disease Control and Prevention (CDC) recommend human immunodeficiency virus (HIV) screening for all persons aged 13 to 64 years who present…”
    Get full text
    Journal Article